2699608-30-3
Chemical Structure
Clarithromycin-13C,d3
- CAS No.: 2699608-30-3
- Formula:C3713CH66D3NO13
- Molecular Weight:751.96
IUPAC Name: (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-6-(((2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methyl(methyl-13C-d3)amino)tetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
InChIKey: AGOYDEPGAOXOCK-NLMDYTMOSA-N
SMILES: O=C1[C@@H](C[C@](C)([C@@H]([C@H]([C@@H]([C@H](C(O[C@@H]([C@](C)([C@@H]([C@H]1C)O)O)CC)=O)C)O[C@]2(C[C@@](OC)([C@H]([C@@H](O2)C)O)C)[H])C)O[C@]3([C@@H]([C@H](C[C@H](O3)C)N([13C]([2H])([2H])[2H])C)O)[H])OC)C
Biological Activity: Clarithromycin-13C,d3 is the deuterium and 13C labeled Clarithromycin[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Clarithromycin-13C,d3 | 99.9% | Clarithromycin-13C,d3 is the deuterium and 13C labeled Clarithromycin. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Clarithromycin (Standard) | 99.93% | Clarithromycin (Standard) is the analytical standard of Clarithromycin. This product is intended for research and analytical applications. Clarithromycin has a broad spectrum of antimicrobial activity. Clarithromycin inhibits the CYP3A4-catalyzed triazolam alpha-hydroxylation with the IC50 (Ki) value of 56 (43) μM. Clarithromycin significantly inhibits the HERG potassium current.Clarithromycin affects the autophagic flux by impairing the signaling pathway linking hERG1 and PI3K. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Clarithromycin-d3 | 99.90% | Clarithromycin-d3 is the deuterium labeled Clarithromycin (HY-17508). Clarithromycin has a broad spectrum of antimicrobial activity. Clarithromycin inhibits the CYP3A4-catalyzed triazolam alpha-hydroxylation with the IC50 (Ki) value of 56 (43) μM. Clarithromycin significantly inhibits the HERG potassium current.Clarithromycin affects the autophagic flux by impairing the signaling pathway linking hERG1 and PI3K. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Clarithromycin | 99.90% | Clarithromycin has a broad spectrum of antimicrobial activity. Clarithromycin inhibits the CYP3A4-catalyzed triazolam alpha-hydroxylation with the IC50 (Ki) value of 56 (43) μM. Clarithromycin significantly inhibits the HERG potassium current.Clarithromycin affects the autophagic flux by impairing the signaling pathway linking hERG1 and PI3K. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
